arrow
P

Paulus Kirchhof

university heart and vascular center hamburg
H指数:130
被引数:19.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Associations of CMR-based pulse wave velocity and aortic distensibility with infrarenal ultrasound-based aortic parameters in the Hamburg City Health Study

基于CMR的脉搏波速度和主动脉顺应性与汉堡市健康研究中肾下超声主动脉参数的关联

2026-09-210
OAAI
Early rhythm control in patients with atrial fibrillation and cancer: A subgroup analysis of the EAST-AFNET 4 trial

房颤合并癌症患者早期节律控制:EAST-AFNET 4试验的亚组分析

2026-09-180
OAAI
A titin truncating variant linked to atrial fibrillation increases atrial profibrotic signalling and cholinergic sensitivity

与心房颤动相关的一种肌联蛋白截断变异体增加了心房的促纤维化信号和胆碱能敏感性

2026-05-270
OAAI
Edoxaban for Stroke Prevention in Atrial Fibrillation in Spain and Portugal: 4-Year Follow-Up of the Observational ETNA-AF-Europe Study

依度沙班在西班牙和葡萄牙心房颤动患者卒中预防中的应用:ETNA-AF-Europe观察性研究4年随访

2026-05-250
OAAI
Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial

根据心房颤动状态,在射血分数降低的心力衰竭中 digitoxin 的应用:DIGIT-HF 试验

2026-05-100
OA
Comprehensive assessment of novel cardiovascular biomarkers in AF

新型心血管生物标志物在房颤中的综合评估

2026-05-010
PRE
Associations between cardiovascular risk factors and diseases with aortic pulse wave velocity and aortic distensibility: magnetic resonance imaging in the Hamburg city health study

心血管风险因素与疾病与主动脉脉搏波速度和主动脉扩张性的关联:汉堡城市健康研究中的磁共振成像

2026-02-090
OAAI
The role of comorbidities on periprocedural complications and outcomes in patients with defibrillators and cardiac resynchronization therapy: insights from the German device registry

合并症对植入除颤器和心脏再同步化治疗患者围术期并发症及预后的影响:德国器械注册研究的启示

2025-12-220
OAAI
Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference

通过针对合并症并减少心房颤动负荷来改变心房颤动管理:第10届AFNET/EHRA共识会议

2025-12-010
PRE
Impact of weight/BMI on clinical and bleeding events in 26 805 atrial fibrillation patients on edoxaban from the Global ETNA-AF Registry

体重/BMI对来自全球ETNA-AF登记研究中26 805例接受依度沙班治疗的房颤患者的临床和出血事件的影响

2025-12-010
PRE
Pulmonary vein isolation and beyond: feasibility and acute outcomes of the lattice-tip dual-energy catheter for complex ablations

肺静脉隔离及更远:网格尖端双能量导管在复杂消融中的应用可行性与即刻效果

2025-11-250
OAAI
Troponin predicts mortality in heart failure-related cardiogenic shock

肌钙蛋白预测心力衰竭相关的心源性休克的死亡率

2025-11-180
OAAI
Temporal trends, patient characteristics and hospital volume outcomes after transcoronary ablation of septal hypertrophy and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy

时间趋势、患者特征及医院病例量对梗阻性肥厚型心肌病经冠状动脉间隔消融术和间隔心肌切除术治疗结果的影响

2025-10-090
OA
Outcomes and Management of Stressor-Associated Atrial Fibrillation

应力相关心房颤动的结局与管理

JACC
IF0
2025-09-150
PRE
Catheter-based left atrial appendage CLOSURE in patients with Atrial Fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial

经导管左心耳闭合术在具有卒中及出血高风险的房颤患者中的应用,与最佳药物治疗比较:前瞻性随机CLOSURE-AF试验的方案与设计

2025-09-120
PRE